Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Mallory Taylor

Has grant

Assistant Professor

University of Washington

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Recent Grants

Grant: Close

Biomarkers of Social Support in Adolescents and Young Adults with Cancer

Open Date: 2024-08-01

Close Date: 2026-07-01

Grant: Open

CAR T PRO plus: A pilot symptom management intervention in children treated with Chimeric Antigen Receptor T-cell therapy

Open Date: 2024-07-01

Close Date: 2029-06-01

Grant: Open

Neuroimmune Stress Biomarkers and Psychosocial Outcomes in Adolescents and Young Adults with Cancer

Open Date: 2023-07-01

Close Date: 2028-06-30

Grant: Close

Neuroimmune Stress Biomarkers and Psychosocial Outcomes in Children with Cancer receiving CAR T-cell Therapy

Open Date: 2023-04-01

Close Date: 2026-04-01

Grant: Close

Understanding the Patient Experience: Symptom Burden in Pediatric Patients Receiving Chimeric Antigen Receptor (CAR) T-cell Therapy

Open Date: 2022-07-01

Close Date: 2024-06-01

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

UNITED STATES

View details

Cecilia Yeung

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Rochelle Bagatell

UNITED STATES

View details

Anthony Sung

Associate Director

University of Kansas Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mallory Taylor

Research Interests

Explore related searches

Recent Grants

Articles (20)

The First-in-Human ENCIT01 Trial Comparing Second- versus Third-Generation L1CAM-specific CAR T Cells in Patients with Primary Refractory or Relapsed Neuroblastoma

Contemporary Ototoxicity Among Patients With High-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL1531

Health‐Related Quality of Life and Symptom Burden in Pediatric Patients Receiving CAR T‐Cell Therapy: A Prospective, Longitudinal Patient‐Reported Outcomes Study

Assessing physical function in transplantation and CAR-T recipients: expert recommendations from the survivorship, aging and biobehavioral special interest groups of ASTCT

Outcomes for Patients Aged 12–18 Months With Metastatic MYCN Non‐Amplified Neuroblastoma and Unfavorable Biologic Features (“Mixed Biology Toddlers”): A Report From the International Neuroblastoma Risk Group (INRG) Project

Promoting Resilience in Stress Management: A Randomized Controlled Trial of a Novel Psychosocial Intervention for Adolescents and Young Adults With Advanced Cancer.

Assessing cognitive function in transplantation and chimeric antigen receptor t cell therapy recipients: Expert recommendations from the survivorship, aging and biobehavioral special interest groups of the American Society for Transplantation and Cellular Therapy

Evolving CAR T-Cell Therapy to Overcome the Barriers in Treating Pediatric Central Nervous System Tumors

Heart Rate Variability as a Digital Biomarker in Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors

Resilience Intervention Improves Stress-Related Gene Expression in Adolescent and Young Adult HCT Recipients

233 Early experience on ENLIGHTen-01: a phase 1 study of FITC-E2 CAR-T cells with CAR adaptor molecule UB-TT170 for relapsed/refractory osteosarcoma

Resilience and distress among adolescents and young adults receiving hematopoietic cell transplantation: The Promoting Resilience in Stress Management randomized trial

STRIvE-02 Arm C: Phase 1 study of concurrent PD-1 inhibition with B7-H3 CAR T cell immunotherapy for recurrent/refractory pediatric solid tumors.

Clinical RNA sequencing clarifies variants of uncertain significance identified by prior testing

Congenital pleuropulmonary blastoma in a newborn with a variant of uncertain significance in DICER1 evaluated by RNA-sequencing

We Grieve Too

Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis

CD43-positive, EWSR1::FLI1-rearranged Soft Tissue Sarcoma in a Pediatric Patient With History of B-Cell Acute Lymphoblastic Leukemia

Biobehavioral Implications of Chimeric Antigen Receptor T-cell Therapy: Current State and Future Directions

Collaborators (12)

Allison Lyle

Robert Ferguson

William Wood

Heather Gustafson

Scott Maurer

Kevin Scott Baker

Kelly Rentscher

Navin Pinto

Mark A. Applebaum

Cecilia Yeung

Rochelle Bagatell

Anthony Sung

Make your next move.